Phibro Animal Health (PAHC) Total Current Liabilities (2013 - 2026)

Phibro Animal Health's (PAHC) quarterly Total Current Liabilities came in at $281.9 million in Q1 2026, up 5.77% year-on-year from $266.5 million in Q1 2025, and little changed quarter-over-quarter from $282.4 million in Q4 2025.

Phibro Animal Health (PAHC) Total Current Liabilities (2013 - 2026) Analysis & Trends

Phibro Animal Health's Total Current Liabilities history runs 14 years deep, the most recent figure standing at $281.9 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 5.77% year-over-year to $281.9 million in Q1 2026; TTM through Mar 2026 was $281.9 million, a 5.77% increase from a year earlier, with the FY2025 full-year figure at $293.5 million, up 43.76% from the prior year.
  • Total Current Liabilities held at $281.9 million in Q1 2026 per PAHC's latest filing, from $282.4 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $293.5 million in Q2 2025 and bottomed at $165.3 million in Q1 2023.
  • The 5-year median for Total Current Liabilities is $189.1 million (2024), against an average of $212.8 million.
  • Across the five-year window, Total Current Liabilities retreated 11.65% in 2023 and jumped 52.71% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $167.6 million in 2022, then climbed by 12.03% to $187.7 million in 2023, then increased by 24.24% to $233.2 million in 2024, then rose by 21.06% to $282.4 million in 2025, then slipped by 0.18% to $281.9 million in 2026.
  • Per Business Quant, the three latest PAHC Total Current Liabilities figures stand at $281.9 million (Q1 2026), $282.4 million (Q4 2025), and $270.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Phibro Animal Health 1.38 Bn 1.30 Bn 125.68 Mn 281.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 281.87 Mn
Dec 31, 2025 282.37 Mn
Sep 30, 2025 270.14 Mn
Jun 30, 2025 293.47 Mn
Mar 31, 2025 266.48 Mn
Dec 31, 2024 233.25 Mn
Sep 30, 2024 176.89 Mn
Jun 30, 2024 204.15 Mn
Mar 31, 2024 189.07 Mn
Dec 31, 2023 187.74 Mn
Sep 30, 2023 172.36 Mn
Jun 30, 2023 176.00 Mn
Mar 31, 2023 165.31 Mn
Dec 31, 2022 167.57 Mn
Sep 30, 2022 172.50 Mn
Jun 30, 2022 190.83 Mn
Mar 31, 2022 187.10 Mn
Dec 31, 2021 166.63 Mn
Sep 30, 2021 152.59 Mn
Jun 30, 2021 164.12 Mn